glp 3 peptide vs retatrutide — 10 mg | Lab Select Comparing the Big 3, Semaglutide,

Its ability to reduce weight significantly and improve metabolic health makes it a breakthrough therapy

Saxenda is contraindicated during pregnancy and breastfeeding

Secondary signals across both trials reduced knee osteoarthritis pain, fewer obstructive sleep apnea events, improvements in triglycerides, blood pressure, LDL, and hsCRP suggest systemic metabolic remodeling rather than simple caloric suppression

This large cohort study used data on more than 145,000 people treated with GLP-1 agonists, and almost 292,000 people treated with DPP4 inhibitors from Norway, Sweden and Denmark

December 20, 2024

2013 Aug;36 Suppl 2(Suppl 2):S245-52